ChronoScale Holdings Corporation filed an 8-K to disclose that its wholly-owned subsidiary, ChronoScale Corporation, entered into an Offer Letter with Jerome Wong on August 16, 2026. The agreement confirms Wong's continued service as Chief Financial Officer with a $400,000 annual base salary and a target performance bonus of 60% of that amount. The filing includes a true-up payment for the period from May 5 through August 16, 2026, reflecting the retroactive salary increase. Additionally, Wong received an award of 300,000 restricted stock units subject to time-based vesting. Severance provisions include nine months of base salary and accelerated RSU vesting upon a Qualifying CIC Termination during the Change in Control Period, or six months of salary continuation for termination without Cause. The company operates in the biotechnology sector, focusing on cellular reprogramming technologies.